Back to Search
Start Over
Birt-Hogg-Dubé syndrome: diagnosis and management
- Source :
- Lancet Oncology, 10(12), 1199-1206. Lancet Publishing Group, Menko, F H, van Steensel, M A M, Giraud, S, Friis-Hansen, L, Richard, S, Ungari, S, Nordenskjold, M, Hansen, T V, Solly, J & Maher, E R 2009, ' Birt-Hogg-Dube syndrome: diagnosis and management ', Lancet Oncology, vol. 10, no. 12, pp. 1199-1206 . https://doi.org/10.1016/S1470-2045(09)70188-3
- Publication Year :
- 2009
-
Abstract
- Summary Birt-Hogg-Dube syndrome (BHD) is an autosomal dominant condition characterised clinically by skin fibrofolliculomas, pulmonary cysts, spontaneous pneumothorax, and renal cancer. The condition is caused by germline mutations in the FLCN gene, which encodes folliculin; the function of this protein is largely unknown, although FLCN has been linked to the mTOR pathway. The availability of DNA-based diagnosis has allowed insight into the great variation in expression of FLCN , both within and between families. Patients can present with skin signs and also with pneumothorax or renal cancer. Preventive measures are aimed mainly at early diagnosis and treatment of renal cancer. This Review gives an overview of current diagnosis and management of BHD.
- Subjects :
- Lung Diseases
Pathology
medicine.medical_specialty
Fibrofolliculoma
Birt–Hogg–Dubé syndrome
Skin Diseases
Germline mutation
Proto-Oncogene Proteins
medicine
Humans
Genetic Testing
Folliculin
PI3K/AKT/mTOR pathway
Germ-Line Mutation
Genetic testing
medicine.diagnostic_test
business.industry
Cysts
Tumor Suppressor Proteins
Cancer
Pneumothorax
Syndrome
medicine.disease
Kidney Neoplasms
Oncology
business
Subjects
Details
- ISSN :
- 14745488 and 14702045
- Volume :
- 10
- Issue :
- 12
- Database :
- OpenAIRE
- Journal :
- The Lancet. Oncology
- Accession number :
- edsair.doi.dedup.....0f48c1c488aaeee4d7e7986feb77855f